Specific analysis of expression profiles of genes associated with increased DDR, alternative mechanisms for p53 inactivation, and distribution of cases with TP53 defect further validated the CLL subtypes in the REACH cohort (Supplementary Fig. 13c, Supplementary Table 9). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.